Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed2
Recruiting2
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT07044310Phase 2Recruiting
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
PrincipalinvestigatorStart date: 2025-07-25
NCT06508034Not ApplicableSuspended
Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy
Malignant Solid Neoplasm
PrincipalinvestigatorStart date: 2024-07-31
NCT04865133Completed
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
COVID-19 InfectionMalignant Solid Neoplasm
PrincipalinvestigatorStart date: 2021-03-31
NCT04517838Recruiting
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more
PrincipalinvestigatorStart date: 2020-07-31
NCT03358511Not ApplicableCompleted
Engineering Gut Microbiome to Target Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2017-10-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT07044310Phase 2PrincipalInvestigator

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
Recruiting
NCT06508034Not ApplicablePrincipalInvestigator

Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy

Malignant Solid Neoplasm
Suspended
NCT04865133PrincipalInvestigator

Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

COVID-19 InfectionMalignant Solid Neoplasm
Completed
NCT04517838PrincipalInvestigator

Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more
Recruiting
NCT03358511Not ApplicablePrincipalInvestigator

Engineering Gut Microbiome to Target Breast Cancer

Breast Cancer
Completed

All 5 trials loaded